Case Presentation: Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow.
What Would You Do: Would you use an implanted port that lacked a blood return to administer non-vesicant chemotherapy?
Oncology nursing and vascular access leaders provide their expert opinions to answer the question of whether a blood return needs be establised to administer non-vesicant chemotherapy.
Living With Multiple Myeloma: Nurses as the Lifeline
In 2001, Doug Rickert, a 46-year-old industrial management consultant and married father of 3, heard the life-altering words, "softball-sized tumor pressing against your spinal canal."
Cancer Screening: Are You Recommending the Right Intervals?
Now more than ever, oncology nurses need to be able to fill the knowledge gap and accurately educate their patients and the public about cancer screening tests and their frequency.
Compassion Fatigue: When Caring Takes Its Toll
Every day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.
The Caring Ambassadors Program
CAP is a nonprofit providing information, resource referrals for personal support, and public advocacy for people at risk for or living with lung cancer or hepatitis C.
Noninvasive Stool Test Effectively Detects Colon Cancer
The iFOBT test examines the stool for hidden blood, which could come from anywhere in the GI tract, and possibly indicates a colon tumor or precancerous growths known as polyps.
Oncology Nutritionists: Should cancer care teams include dietary experts?
Early screening and comprehensive assessment of risk for malnutrition is increasingly recognized as imperative in the development of standards of quality of care in oncology practices.
Frontline Ribociclib Plus Endocrine Therapy Provides PFS Benefit in Pre/Perimenopausal HR+/HER2- Advanced Breast Cancer
Chemotherapy Followed by Endocrine Therapy Could Increase Cognitive Impairment in Breast Cancer, Irrespective of Menopausal Status
Racial Disparity Revealed in Prometastatic TME in Women With Residual Breast Cancer After Neoadjuvant Chemo
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.